Listed

PharmaCyte Biotech, Inc.

PMCBNasdaqCIK 1157075HealthcareFiscal year ends Apr 30

Reports and events: 211 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

PharmaCyte Biotech, Inc., Reports and events
FiledFormWhat it isAccession number
2014-03-1706:06 ET10-QQuarterly reportPeriod 2014-01-310001019687-14-000850
2014-03-0617:27 ET8-K1.01 Entry into a material agreement0001019687-14-000740
2014-02-1917:15 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001019687-14-000585
2013-12-1606:04 ET10-QQuarterly reportPeriod 2013-10-310001019687-13-004824
2013-12-0216:16 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001019687-13-004678
2013-11-2516:44 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001019687-13-004633
2013-09-1618:33 ET10-QQuarterly reportPeriod 2013-07-310001157075-13-000015
2013-07-3016:06 ET10-K/AAnnual report, amendedPeriod 2013-04-300001157075-13-000012
2013-07-2916:18 ET10-KAnnual reportPeriod 2013-04-300001157075-13-000010
2013-07-1820:19 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001157075-13-000007
2013-04-2516:20 ET10-Q/AQuarterly report, amendedPeriod 2011-07-310001157075-13-000005
2013-03-2618:13 ET10-QQuarterly reportPeriod 2013-01-310001445305-13-000706
2013-02-1515:51 ET8-K2.01 Completion of an acquisition or disposition0001445305-13-000233
2012-12-2616:46 ET10-QQuarterly reportPeriod 2012-10-310001445305-12-003886
2012-09-1916:28 ET10-QQuarterly reportPeriod 2012-07-310001262463-12-000355
2012-08-1415:48 ET10-KAnnual reportPeriod 2012-04-300001262463-12-000335
2012-06-2809:34 ET8-K2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001262463-12-000242
2012-03-2609:48 ET10-Q/AQuarterly report, amendedPeriod 2011-07-310001262463-12-000085
2012-03-2115:26 ET10-QQuarterly reportPeriod 2012-01-310001262463-12-000081
2012-02-2918:17 ET8-K/A4.01 Change of auditor; 9.01 Financial statements and exhibits0001262463-12-000044
2012-02-1514:44 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001262463-12-000033
2012-01-2417:25 ET8-K5.02 Departure or appointment of officers or directors0001262463-12-000015
2011-12-1515:00 ET10-QQuarterly reportPeriod 2011-10-310001262463-11-000325
2011-09-2016:37 ET10-Q/AQuarterly report, amendedPeriod 2011-07-310001262463-11-000192
2011-09-1915:20 ET10-QQuarterly reportPeriod 2011-07-310001262463-11-000184
2011-08-1515:19 ET10-KAnnual reportPeriod 2011-04-300001262463-11-000129
2011-07-2510:43 ET8-K3.01 Delisting notice; 9.01 Financial statements and exhibits0001262463-11-000098
2011-06-0816:43 ET10-Q/AQuarterly report, amendedPeriod 2010-10-310001262463-11-000071
2011-06-0816:38 ET10-Q/AQuarterly report, amendedPeriod 2010-07-310001262463-11-000070
2011-04-2616:54 ET10-Q/AQuarterly report, amendedPeriod 2010-10-310001262463-11-000047
2011-04-2616:50 ET10-Q/AQuarterly report, amendedPeriod 2010-07-310001262463-11-000046
2011-04-2616:48 ET10-K/AAnnual report, amendedPeriod 2010-04-300001262463-11-000045
2011-04-2616:43 ET8-K/A4.02 Non-reliance on financial statements0001262463-11-000044
2011-03-0818:52 ET10-QQuarterly reportPeriod 2011-01-310001262463-11-000031
2011-03-0216:07 ET8-K5.02 Departure or appointment of officers or directors0001262463-11-000029
2011-03-0215:36 ET8-K/A4.02 Non-reliance on financial statements0001262463-11-000027
2011-02-0314:10 ET8-K5.02 Departure or appointment of officers or directors0001262463-11-000018
2011-01-3111:58 ET8-K4.02 Non-reliance on financial statements0001262463-11-000015
2011-01-2818:28 ET10-QQuarterly reportPeriod 2010-10-310001262463-11-000012
2011-01-1416:23 ET10-QQuarterly reportPeriod 2010-07-310001262463-11-000007
2011-01-1416:19 ET8-K/A3.01 Delisting notice; 4.02 Non-reliance on financial statements0001262463-11-000006
2010-12-2915:49 ET10-KAnnual reportPeriod 2010-04-300001262463-10-000148
2010-09-2220:04 ET8-K5.02 Departure or appointment of officers or directors0001262463-10-000104
2010-09-1514:46 ET8-K3.01 Delisting notice; 4.02 Non-reliance on financial statements; 9.01 Financial statements and exhibits0001099910-10-000137
2010-03-2918:03 ET8-K/A4.01 Change of auditor; 9.01 Financial statements and exhibits0001099910-10-000012
2010-03-2216:41 ET10-QQuarterly reportPeriod 2010-01-310001099910-10-000008
2010-03-0911:57 ET8-K4.01 Change of auditor0001262463-10-000019
2009-12-2115:22 ET10-QQuarterly reportPeriod 2009-10-310001262463-09-000104
2009-11-0616:06 ET8-K5.02 Departure or appointment of officers or directors0001262463-09-000091
2009-10-0111:44 ET8-K3.02 Unregistered sale of equity0001262463-09-000082

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 20:52 ET. Listed shows no prices and gives no investment advice.